LIR Life Sciences Corp.
BBCMF
$0.07
-$0.18-73.76%
OTC PK
| 01/31/2026 | 10/31/2025 | 01/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.07% | 40,073.68% | -- | ||
| Total Receivables | 136.60% | 73.86% | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 605.41% | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -2.38% | 7,244.86% | -- | ||
|
|
|||||
| Total Current Assets | -2.38% | 7,244.86% | -- | ||
| Net Property, Plant & Equipment | -- | -- | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | 2.05% | -2.53% | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | -2.01% | 900.23% | -- | ||
|
|
|||||
| Total Accounts Payable | -84.32% | 35.44% | -- | ||
| Total Accrued Expenses | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | -84.32% | 23.88% | -- | ||
|
|
|||||
| Total Current Liabilities | -84.32% | 23.88% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -84.32% | 23.88% | -- | ||
|
|
|||||
| Common Stock & APIC | 130.02% | 386.34% | -- | ||
| Retained Earnings | -287.24% | -31.47% | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 59.46% | 333.46% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 59.46% | 333.46% | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 59.46% | 333.46% | -- | ||
|
|
|||||